🇧🇷 Vumerity in Brazil

Vumerity (DIROXIMEL FUMARATE) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

Vumerity in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Brazil

Frequently asked questions

Is Vumerity approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for Vumerity in Brazil?

Biogen is the originator. The local marketing authorisation holder may differ — check the official source linked above.